Implications of systemic dysfunction for the etiology of malignancy

Area of Science:

• Oncology
• Systems Biology
• Preventive Medicine

Background:

• Current oncology treatments often use cytotoxic chemotherapies or targeted pharmaceuticals to inactivate specific molecular targets driving cancer.
• This approach assumes malignancy stems from individual pathways and treatment should focus on destroying the tumor or pathway.
• However, evidence suggests systemic dysfunction precedes pathway disruption in many adult cancers, and targeted therapies can cause unintended effects.

Purpose of the Study:

• To address the assumptions underlying current targeted cancer therapies.
• To discuss the systemic basis of malignancy.
• To propose a paradigm shift in cancer treatment and prevention.

Main Methods:

• Review of accumulating evidence on cancer development and treatment.
• Discussion of the systemic basis of malignancy.
• Exploration of early detection and prevention strategies.
• Consideration of quantitative systems modeling for cancer progression.

Main Results:

• Systemic dysfunction appears to precede specific pathway disruptions in most adult cancers.
• Targeted therapies can lead to unintended consequences in non-targeted pathways.
• Early detection of pre-cancerous biomarkers and lifestyle modifications are crucial for prevention.
• Restoring systemic balance and strengthening innate defenses may be effective for early-stage tumors.

Conclusions:

• The current targeted therapy model in oncology needs re-evaluation.
• A systems-based approach focusing on systemic health and early prevention is essential.
• Future strategies should prioritize restoring balance and enhancing the body's defenses over solely targeting specific pathways.